AI-generated summary
The authors combined cisplatin with Photogem-mediated photodynamic therapy in mouse colon cancer cells (CT-26) in vitro and in established tumors in mice. They report that the combination was associated with lower recurrence at day 14 than PDT alone, though cell viability results were mixed. The study is limited to cell and animal work, and the authors suggest the combination may allow lower doses of Photogem and cisplatin.
- Who or what was studied
- Mouse colon cancer cells (CT-26) in vitro and established CT-26 tumors in mice
- Wavelengths
- 632 nm
- Limits stated in the abstract
- The study used cell culture and animal models only, so the results may not apply to humans.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 632 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photodynamic therapy, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.